High expression of CRAM correlates with poor prognosis in patients with cervical carcinoma.

URG4 overexpression is correlated with cervical cancer progression and poor prognosis in patients with early-stage cervical cancer. BMC Cancer (2014) 0.84

Senescent fibroblast-derived Chemerin promotes squamous cell carcinoma migration. Oncotarget (2016) 0.75

Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet (2009) 6.98

Tuning inflammation and immunity by chemokine sequestration: decoys and more. Nat Rev Immunol (2006) 2.92

Involvement of a novel chemokine decoy receptor CCX-CKR in breast cancer growth, metastasis and patient survival. Clin Cancer Res (2009) 1.77

The chemokine system in cancer biology and therapy. Cytokine Growth Factor Rev (2009) 1.75

Mast cell-expressed orphan receptor CCRL2 binds chemerin and is required for optimal induction of IgE-mediated passive cutaneous anaphylaxis. J Exp Med (2008) 1.74

Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2012) 1.60

The atypical chemokine receptor D6 suppresses the development of chemically induced skin tumors. J Clin Invest (2007) 1.46

Guidelines for the treatment of recurrent and metastatic cervical cancer. Oncologist (2002) 1.41

The Duffy antigen/receptor for chemokines (DARC) regulates prostate tumor growth. FASEB J (2006) 1.33

A novel lipopolysaccharide inducible C-C chemokine receptor related gene in murine macrophages. FEBS Lett (1998) 1.08

LPS-induced expression of a novel chemokine receptor (L-CCR) in mouse glial cells in vitro and in vivo. Glia (2003) 1.04

CCL19 is a specific ligand of the constitutively recycling atypical human chemokine receptor CRAM-B. Immunology (2009) 1.02

Cloning and characterization of a novel human chemokine receptor. Biochem Biophys Res Commun (1998) 1.01

What is the difference between squamous cell carcinoma and adenocarcinoma of the cervix? A matched case-control study. Int J Gynecol Cancer (2006) 1.01

Management of early and locally advanced cervical cancer. Semin Oncol (2009) 1.00

Nonredundant role of CCRL2 in lung dendritic cell trafficking. Blood (2010) 0.98

Distribution and regulation of expression of the putative human chemokine receptor HCR in leukocyte populations. Eur J Immunol (2002) 0.97

Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2010) 0.97

Atypical chemokine receptors. Exp Cell Res (2011) 0.96

Chemokine sequestration by atypical chemokine receptors. Biochem Soc Trans (2006) 0.92

Prognosis of the adenocarcinoma of the cervix uteri: a comparative study. Gynecol Oncol (1989) 0.87

Human B cells express the orphan chemokine receptor CRAM-A/B in a maturation-stage-dependent and CCL5-modulated manner. Immunology (2008) 0.87

Role of the atypical chemoattractant receptor CRAM in regulating CCL19 induced CCR7 responses in B-cell chronic lymphocytic leukemia. Mol Cancer (2010) 0.87

Coexpression of atypical chemokine binders (ACBs) in breast cancer predicts better outcomes. Breast Cancer Res Treat (2010) 0.83

Atypical chemokine receptors predict lymph node metastasis and prognosis in patients with cervical squamous cell cancer. Gynecol Oncol (2013) 0.82

Elevated chemokine CC-motif receptor-like 2 (CCRL2) promotes cell migration and invasion in glioblastoma. Biochem Biophys Res Commun (2012) 0.81

Atypical chemokine receptors: from silence to sound. Biochem Soc Trans (2013) 0.80

Atypical chemokine receptors in renal inflammation. Nephron Exp Nephrol (2010) 0.79